Clinical Trial Update: Implementation of Metformin theraPy to Ease Decline of Kidney Function in Polycystic Kidney Disease (IMPEDE-PKD) [Phase 3]

View source ↗

Summary

Ongoing Phase 3 trial IMPEDE-PKD is evaluating metformin therapy to slow the decline in kidney function for autosomal dominant polycystic kidney disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autosomal Dominant Polycystic Kidney Disease

Drugs mentioned

• metformin (metformin)

Snippet

Sponsor: The University of Queensland | Conditions: Autosomal Dominant Polycystic Kidney Disease | Phase 3 | Status: RECRUITING